Share This Author
Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation.
- H. Harada, H. Nakagawa, A. Rustgi
- Biology, MedicineMolecular cancer research : MCR
- 1 August 2003
TLDR
Cell cycle dysregulation in oral cancer.
TLDR
Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
- J. Harder, B. Riecken, H. Henß
- Medicine, BiologyBritish Journal of Cancer
- 12 September 2006
TLDR
A mouse model of human oral-esophageal cancer.
- O. Opitz, H. Harada, A. Rustgi
- Biology, MedicineThe Journal of clinical investigation
- 15 September 2002
TLDR
Effect of vardenafil, an inhibitor of phosphodiesterase‐5, on portal haemodynamics in normal and cirrhotic liver – results of a pilot study
- P. Deibert, Y. Schumacher, W. Kreisel
- MedicineAlimentary pharmacology & therapeutics
- 1 January 2006
Background Dysregulation of the cyclic guanosine 3′,5′ monophosphate–nitric oxide system is in part responsible for portal hypertension in cirrhosis.
Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver
TLDR
Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response.
- O. Opitz, K. Pietsch, S. Ehlers, E. Jacobs
- Biology, MedicineImmunobiology
- 1 March 1997
Ha-RasG12V induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction
- M. Takaoka, H. Harada, H. Nakagawa
- Biology, MedicineOncogene
- 2 September 2004
TLDR
Prognostic Relevance of Carbohydrate Antigen 19-9 Levels in Patients with Advanced Biliary Tract Cancer
- J. Harder, O. Kummer, M. Olschewski, F. Otto, H. Blum, O. Opitz
- Medicine, BiologyCancer Epidemiology Biomarkers & Prevention
- 1 October 2007
TLDR
Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism.
- O. Opitz, Y. Suliman, W. Hahn, H. Harada, H. Blum, A. Rustgi
- Biology, MedicineThe Journal of clinical investigation
- 1 September 2001
TLDR
...
...